DOCSLIB.ORG

Tocilizumab in Refractory Aortitis: Study on 16 Patients

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Tocilizumab in Refractory Aortitis: Study on 16 Patients Review Tocilizumab in refractory aortitis: a study on 16 patients and literature review J. Loricera1*, R. Blanco1*, S. Castañeda2, A. Humbría2, N. Ortego-Centeno3, J. Narváez4, C. Mata5, S. Melchor6, E. Aurrecoechea7, J. Calvo-Alén7, P. Lluch8, C. Moll8, M. Mínguez9, G. Herrero-Beaumont10, B. Bravo11, E. Rubio12, M. Freire13, E. Peiró1, C. González-Vela1, J. Rueda-Gotor1, T. Pina1, N. Palmou-Fontana14, V. Calvo-Río1, F. Ortiz-Sanjuán1, M.A. González-Gay1 1Dept. of Rheumatology, Hospital ABSTRACT Conclusion. TCZ appears to be effec- Universitario Marqués de Valdecilla, Objective. Non-infectious aortitis is of- tive and relatively safe in patients with 2 IDIVAL, Santander; Dept. of Rheumatology, ten refractory to standard immunosup- inflammatory aortitis refractory to cor- Hospital Universitario La Princesa, IIS-Princesa, Madrid; 3Dept. of Autoimmune pressive therapy. Since IL-6 has been ticosteroids or to other biologic immu- Diseases, Hospital San Cecilio, Granada; implicated in the pathogenesis of aorti- nosuppressive drugs. 4Dept. of Rheumatology, Hospital tis, we assessed the efficacy of the anti- Universitari de Bellvitge, L´Hospitalet de IL6 receptor monoconal antibody toci- Introduction 5 Llobregat, Barcelona; Dept. of lizumab (TCZ) in a series of patients Aortitis encompasses a wide spectrum Rheumatology, Hospital de Laredo; with refractory non-infectious aortitis. of infectious and non-infectious patho- 6Dept. of Rheumatology, Hospital Universitario 12 de Ocubre, Madrid; Methods. Review of 16 patients (14 logic conditions characterised by in- 7Dept. of Rheumatology, Hospital de women/2 men) with refractory aortitis flammation of the aortic wall. In some Sierrallana, Torrelavega; 8Dept. of diagnosed by imaging (CT angiogra- cases it may be associated with severe Rheumatology, Hospital Mateu Orfila, phy, MR angiography, and/or PET) complications such as aneurysms, dis- 9 Menorca; Dept. of Rheumatology, that were treated with TCZ. section and rupture of the aorta (1-4). Hospital Universitario San Juan, Alicante; 10Bone and Joint Research Laboratory, Results. The mean age±SD was Giant cell arteritis (GCA) and Takayasu IIS-Fundación Jiménez Díaz, Madrid; 51.4±20.1 years. The underlying con- arteritis (TakA) including in the cat- 11Paediatric Rheumatology Unit, Hospital ditions were: Takayasu arteritis (TakA) egory of large-vessel vasculitides are Virgen de las Nieves, Granada; 12Dept. of (n=7 cases), giant cell arteritis (GCA) probably the most frequent causes of Rheumatology, Hospital Virgen del Rocío, (n=7), relapsing polychondritis (RP) 13 non-infectious aortitis. Nevertheless, Sevilla; Dept. of Rheumatology, Complexo (n=1), and aortitis associated with re- non-infectious aortitis may present as Hospitalario A Coruña (CHUAC); 14Rheumatology Division, Hospital troperitoneal fibrosis (n=1). TCZ was an isolated entity or be associated with General de Almansa, Albacete, Spain. the first biologic drug used in all pa- other well defined conditions (2, 5- 8). *Javier Loricera and Ricardo Blanco tients with GCA and in the patient with First-line treatment in non-infectious shared first authorship. aortitis associated with retroperitoneal aortitis includes the use of corticos- Please address correspondence to: fibrosis but in only 2 of 7 TakA patients. teroids, usually at high doses (9-12). Miguel A. González-Gay or Ricardo In the remaining cases anti-TNF inhibi- Other therapies are often required to Blanco, Rheumatology Division, tors were prescribed before TCZ (stand- achieve control of the disease or as Hospital Universitario Marqués ard dose was 8 mg/kg/iv/4 weeks). Af- corticosteroid sparing agents. Differ- de Valdecilla, IDIVAL, Avda. Valdecilla ter a mean±SD follow-up of 11.8±6.6 ent synthetic traditional immunosup- s/n., 39008, Santander, Spain. E-mail: [email protected] months most patients experienced clini- pressive drugs such as methotrexate or: [email protected] cal improvement, showing reduction (MTX), azathioprine or cyclophospha- Received on December 26, 2013; accepted of erythrocyte sedimentation rate from mide have been used for this purpose in revised form on February 4, 2014. 43±36 mm/1st h to 5±4 mm/1st h at last (13-18). However, the efficacy of these Clin Exp Rheumatol 2014; 32 (Suppl. 82): visit. At TCZ onset, 25% of patients had drugs to control the activity of the dis- S79-S89. fever and 19% polymyalgia rheumatica. ease is often insufficient and they are © Copyright CLINICAL AND These manifestations disappeared after frequently associated with potential se- EXPERIMENTAL RHEUMATOLOGY 2014. 3 months of TCZ therapy. A corticos- vere side effects. teroid sparing effect was also achieved In patients with large-vessel vasculitis, Key words: aortitis, giant cell arteritis, (from 27.3±17.6 mg/day of prednisone especially in GCA, a number of studies Takayasu arteritis, idiopathic aortitis, at TCZ onset to 4.2±3.8 mg/day at last have shown the presence of abnormal tocilizumab visit). TCZ had to be discontinued in a production of pro-inflammatory cyto- Competing interests: none declared. patient because of severe neutropenia. kines, such as interleukin-1 (IL-1), S-79 REVIEW Aortitis and tocilizumab / J. Loricera et al. IL-6, IL-18, tumour necrosis factor-α TakA fulfilled the 1990 ACR criteria respectively. We defined high CRP val- (TNF-α) or interferon-γ, by T lympho- for the classification for this vasculitis ue when it was higher than 0.5 mg/dL. cytes and macrophages (19-35). Due (51). A patient with aortitis was diag- to this, several studies were performed nosed as having relapsing polychondri- Statistical analysis to determine the efficacy of anti-TNF tis according to the criteria proposed by Statistical analysis was performed us- drugs on large-vessel vasculitides. Re- Michet et al. (52). Another patient with ing the software STATISTICA (Stat- grettably, in most cases, evidence sup- aortitis also fulfilled definitions for re- Soft Inc. Tulsa, Oklahoma, USA). Re- porting the use of anti-TNF-α inhibi- troperitoneal fibrosis (53). Polymyal- sults were expressed as mean±SD for tors in aortitis refractory to corticoster- gia rheumatica (PMR) in the setting of variables with normal distribution, or as oids is weak (36-40). GCA was diagnosed according to the median, range or [25th-75th interquartile IL-6 is another pro-inflammatory piv- criteria proposed by Chuang et al. (54). range (IQR)] when they were not nor- otal cytokine that has been implicated In most cases management started with mally distributed. in the pathogenesis of aortitis (26, 35, corticosteroids. In a second phase, All of the following variables were 41-43). Since tocilizumab (TCZ) is a synthetic traditional immunosuppres- compared: clinical manifestations, humanised monoclonal anti-IL6 recep- sive drugs and in some cases biologic ESR, CRP, and daily prednisone dose. tor (IL-6R) antibody, the use of this therapy was given. Comparisons of these variables were monoclonal antibody was described in Before biologic treatment, evidence of made between baseline and 3, 6 and some case reports and small series. The malignancy or systemic infection was 12 months after initiation of treatment. analysis of these reports suggests a po- excluded including hepatitis B or hepa- Comparison of continuous variables tential efficacy of TCZ therapy in the titis C. According to national guide- was performed using the Wilcoxon test. treatment of aortitis, mainly in the set- lines in all patients receiving biologic ting of GCA and TakA (40, 43, 44-49). drugs latent tuberculosis was excluded Results To further investigate into the potential by a tuberculin skin testing (PPD) and/ We studied 16 patients (14 women and efficacy of anti-IL6-R blockade in pa- or quantiferon and chest radiograph. In 2 men) with non-infectious aortitis. tients with large-vessel vasculitis, we patients with latent tuberculosis proph- The mean-age ± SD was 51.4±20.1 assessed a series of patients with non- ylaxis with isoniazid was initiated at years (range: 7–77 years). Table I sum- infectious aortitis refractory to corti- least 4 weeks before the onset of the marises the main features of the pa- costeroids and in some cases to anti- biologic therapy. Overall, prophylaxis tients included in this series. Aortitis TNF-α inhibitors. with isoniazid was maintained for 9 was associated to the following under- months. Since TCZ is an off-label indi- lying conditions: TakA (n=7 patients), Patients and methods cation in non infectious aortitis, written GCA (n=7), relapsing polychondritis Patient population informed consent was requested and (n=1), and aortitis with retroperitoneal We conducted an interventional case obtained from all patients. fibrosis (n=1). series, open-label, multicentre study on As discussed Methods, the diagnosis 16 patients diagnosed as having non- Data collection and clinical definitions of aortitis was made by imaging tech- infectious aortitis, either idiopathic or Clinical and laboratory data were ex- niques such as FDG PET/CT scan, MR in the setting of well-defined autoim- tracted from the clinical records accord- angiography, and/or CT angiography. mune or inflammatory conditions. In ing to a specifically designed protocol In the patient with aortitis and retro- all of them, TCZ therapy was given that was designed beforehand. They peritoneal fibrosis the diagnosis was because patients were refractory to were stored in a computerised file. To performed by a retroperitoneal biopsy. corticosteroids and standard synthetic minimise entry error, all the data were In 15 cases
Load more

Recommended publications
  • Cogan's Syndrome
    IMAGING IN MEDICINE COLODETTI R ET AL. Cogan’s syndrome – A rare aortitis, difficult to diagnose but with therapeutic potential RAIZA COLODETTI1, GUILHERME SPINA2, TATIANA LEAL3, MUCIO OLIVEIRA JR4, ALEXANDRE SOEIRO3* 1MD Cardiologist, Instituto do Coração (InCor), Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil 2Assistant Physician at the Valvular Heart Disease Outpatient Clinic, InCor, HC-FMUSP, São Paulo, SP, Brazil 3Assistant Physician at the Clinical Emergency Service, InCor, HC-FMUSP, São Paulo, SP, Brazil 4Director of the Clinical Emergency Service, InCor, HC-FMUSP, São Paulo, SP, Brazil SUMMARY Study conducted at Unidade Clínica de Emergência, Instituto do Coração (InCor), The inflammation of aortic wall, named aortitis, is a rare condition that can Hospital das Clínicas, Faculdade de be caused by a number of pathologies, mainly inflammatory or infectious in Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil nature. In this context, the occurrence of combined audiovestibular and/or ocular manifestations eventually led to the diagnosis of Cogan’s syndrome, Article received: 8/18/2017 Accepted for publication: 9/9/2017 making it the rare case, but susceptible to adequate immunosuppressive treatment and satisfactory disease control. *Correspondence: Address: Av. Dr. Enéas de Carvalho Aguiar, 44 Keywords: chest pain, aortitis, Cogan’s syndrome. São Paulo, SP – Brazil Postal code: 05403-900 [email protected] http://dx.doi.org/10.1590/1806-9282.63.12.1028 INTRODUCTION four years ago the episodes began to intensify. He was Inflammation of the aortic wall, called aortitis, is an in- admitted to another service a week before for the same frequent clinical condition that manifests itself with sys- reason, where he underwent coronary angiography, show- temic symptoms and may cause precordial pain.1-4 One ing no coronary obstruction, and an echocardiogram, of the rheumatologic causes of aortitis is a rare disease which revealed a slight dilatation of the ascending aorta.
    [Show full text]
  • Noninfectious Ascending Aortitis: Staying Ahead of the Curve
    Editorial Noninfectious Ascending Aortitis: Staying Ahead of the Curve Aortitis is the general name for a spectrum of disorders aortic aneurysms is common with aortitis, the vast majority involving inflammation of the aorta1. The causes of aortitis of aortic aneurysms, both thoracic and abdominal, are due are most easily sorted into either infectious or noninfectious to noninflammatory disease including cystic medial degen- disease. Infections associated with aortitis include syphilis, eration, atherosclerosis, inherited connective tissue dis- Salmonella, Staphylococcus, other bacteria, and mycobacte- eases, or a combination of these processes8. ria, especially M. tuberculosis. Noninfectious causes of aor- The most common serious clinical sequelae of aortitis titis include several forms of primary and secondary are thoracic aortic aneurysms, especially of the ascending large-vessel vasculitis. Giant cell arteritis (GCA) and aorta. The rate of aortic aneurysms among patients with Takayasu’s arteritis are the most common causes of nonin- aortitis is markedly elevated compared to the general popu- fectious aortitis. At least 20% of patients with GCA and lation, especially for ascending thoracic lesions. The reason 50%–70% of patients with Takayasu’s arteritis will develop for this differential tropism for the proximal versus distal changes consistent with aortitis, many of whom develop aorta in aortitis, which is the opposite of what is seen in aortic aneurysms2-7. Aortic involvement is also seen in noninflammatory aortic aneurysms, is not clear but may be relapsing polychondritis, Cogan’s syndrome, and Behçet’s related to differences in the tissue structure, presence of disease, and has been reported as a rare association with vasa vasorum, blood flow dynamics, and other factors9.
    [Show full text]
  • Survival After Aortic Dissection in Giant Cell Arteritis
    332 Letters to the editor pressure or hypotensive episodes were technique and rating scale for abnormalities of the thorax, without intravenous contrast seen in scleroderma and related disorders. recorded during the trial. Among the side Arthritis Rheum 1981; 24: 1159-65. medium (because of asthma), showed a effects, mild flushing (35%) and headache 9 Ferri C, La Civita L, Zignego A et al. Plasma normal mediastinum but a small rim of L, Ann Rheum Dis: first published as 10.1136/ard.55.5.332 on 1 May 1996. Downloaded from (24%) were the most frequent in isradipine levels of endothelin-I in mixed cryoglobulin- pleural fluid on the left. aemia patients. Br J Rheumatol 1994; 33: recipients. 689-90. At follow up, the patient complained of This study has demonstrated the favour- 10 Yanagisawa M, Kurihara H, Kimura S, et al. A right thigh claudication. Radiofemoral delay able effects of isradipine on patients with novel potent vasoconstrictor peptide pro- was noted. CT of the abdomen showed Raynaud's phenomenon; moreover, it is the duced by vascular endothelial cells. Nature internal displacement ofcalcified atheroma in 1988; 332: 411-5. first to demonstrate a significant reduction 11 Levin E R. Endothelins [review]. N Engl J Med the aorta, suggesting aortic dissection. Mag- in plasma concentrations of ET-1 during 1995; 333: 356-63. netic resonance imaging (MRI) confirmed calcium antagonist treatment. The most this as distal to the origin of the left sub- usual manifestations of Raynaud's phenom- clavian artery, extending to the aortic bifur- enon are pain and numbness in the fingers, cation.
    [Show full text]
  • Statistical Analysis Plan
    Cover Page for Statistical Analysis Plan Sponsor name: Novo Nordisk A/S NCT number NCT03061214 Sponsor trial ID: NN9535-4114 Official title of study: SUSTAINTM CHINA - Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Document date: 22 August 2019 Semaglutide s.c (Ozempic®) Date: 22 August 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL Clinical Trial Report Status: Final Appendix 16.1.9 16.1.9 Documentation of statistical methods List of contents Statistical analysis plan...................................................................................................................... /LQN Statistical documentation................................................................................................................... /LQN Redacted VWDWLVWLFDODQDO\VLVSODQ Includes redaction of personal identifiable information only. Statistical Analysis Plan Date: 28 May 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL UTN:U1111-1149-0432 Status: Final EudraCT No.:NA Page: 1 of 30 Statistical Analysis Plan Trial ID: NN9535-4114 Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Author Biostatistics Semaglutide s.c. This confidential document is the property of Novo Nordisk. No unpublished information contained herein may be disclosed without prior written approval from Novo Nordisk. Access to this document must be restricted to relevant parties.This
    [Show full text]
  • An Elevated Igg4 Response in Chronic Infectious Aortitis Is Associated with Aortic Atherosclerosis Zakir Siddiquee1, R Neal Smith1 and James R Stone1,2
    Modern Pathology (2015) 28, 1428–1434 1428 © 2015 USCAP, Inc All rights reserved 0893-3952/15 $32.00 An elevated IgG4 response in chronic infectious aortitis is associated with aortic atherosclerosis Zakir Siddiquee1, R Neal Smith1 and James R Stone1,2 1Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA and 2Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA Recently, it was shown that infectious bacterial aortitis can stimulate an elevated IgG4+ plasma cell response in the vessel wall, which could mimic IgG4 aortitis/periaortitis. However, the factors that are associated with an elevated IgG4+ plasma cell response in infectious aortitis are unclear. To ascertain these factors, 17 cases of infectious aortitis and 6 cases of non-infectious severe abdominal aortic atherosclerosis were assessed for the magnitude of IgG4+ plasma cell response. The degree of IgG4+ plasma cell infiltration was determined by immunohistochemistry. Infectious cases were subcharacterized as chronic (43 weeks duration) or acute (o3 weeks duration) based on the duration of symptoms, and as involving either the ascending aorta or the distal aorta, ie, the descending thoracic and/or abdominal aorta. There was a 5–16-fold greater degree of IgG4+ plasma cell infiltration in the chronic distal infectious aortitis group compared with the other three infectious aortitis groups (P ≤ 0.0007), and compared with non-infectious severe abdominal aortic atherosclerosis (Po0.0008). This resulted in a greater IgG4/IgG ratio in the chronic distal infectious aortitis group compared with the acute ascending and acute distal infectious aortitis groups (Po0.03). The degree of IgG4+ plasma cell infiltration in chronic distal infectious aortitis overlaps with that seen in the aortitis and periaortitis of IgG4-related disease.
    [Show full text]
  • Peripheral Vascular Disease Imaging Guidelines
    Cigna Medical Coverage Policies – Radiology Peripheral Vascular Disease (PVD) Imaging Guidelines Effective October 1, 2021 ____________________________________________________________________________________ Instructions for use The following coverage policy applies to health benefit plans administered by Cigna. Coverage policies are intended to provide guidance in interpreting certain standard Cigna benefit plans and are used by medical directors and other health care professionals in making medical necessity and other coverage determinations. Please note the terms of a customer’s particular benefit plan document may differ significantly from the standard benefit plans upon which these coverage policies are based. For example, a customer’s benefit plan document may contain a specific exclusion related to a topic addressed in a coverage policy. In the event of a conflict, a customer’s benefit plan document always supersedes the information in the coverage policy. In the absence of federal or state coverage mandates, benefits are ultimately determined by the terms of the applicable benefit plan document. Coverage determinations in each specific instance require consideration of: 1. The terms of the applicable benefit plan document in effect on the date of service 2. Any applicable laws and regulations 3. Any relevant collateral source materials including coverage policies 4. The specific facts of the particular situation Coverage policies relate exclusively to the administration of health benefit plans. Coverage policies are not recommendations for treatment and should never be used as treatment guidelines. This evidence-based medical coverage policy has been developed by eviCore, Inc. Some information in this coverage policyy m nota ap ply to all benefit plans administered by Cigna. These guidelines include procedures eviCore does not review for Cigna.
    [Show full text]
  • NIH Public Access Author Manuscript Circulation
    NIH Public Access Author Manuscript Circulation. Author manuscript; available in PMC 2009 October 9. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Circulation. 2008 June 10; 117(23): 3039±3051. doi:10.1161/CIRCULATIONAHA.107.760686. Aortitis Heather L. Gornik, M.D., M.H.S. and Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Medical Director, Non-Invasive Vascular Laboratory Department of Cardiovascular Medicine The Cleveland Clinic Foundation 9500 Euclid Avenue/Desk S60 Cleveland, Ohio 44120 (216) 445-3689 [email protected] Mark A. Creager, M.D.* Professor of Medicine, Harvard Medical School Simon C. Fireman Scholar in Cardiovascular Medicine Director, Vascular Center Brigham and Women's Hospital 75 Francis Street Boston, Massachusetts 02115 (617) 732-5267 [email protected] Keywords Aortitis; vasculitis; giant cell arteritis; Takayasu arteritis; aortic aneurysm Aortitis is the all-encompassing term ascribed to inflammation of the aorta. The most common causes of aortitis are the large vessel vasculitides, giant cell arteritis (GCA) and Takayasu arteritis, although it is also associated with several other rheumatologic diseases. Infectious aortitis is a rare but potentially life-threatening disorder. In some cases, aortitis is an incidental finding at the time of histopathologic examination following surgery for aortic aneurysm. As the clinical presentation of aortitis is highly variable, the cardiovascular clinician must have a high index of suspicion to establish an accurate diagnosis of this disorder in a timely fashion. In this manuscript, we review the pathophysiology, epidemiology, diagnostic approach, and management of aortitis.
    [Show full text]
  • Retroperitoneal Fibrosis and Aortitis As the Initial Findings of Systemic Lupus Erythematosus
    Turk J Rheumatol 2011;26(3):262-264 doi: 10.5152/tjr.2011.042 Case Report Retroperitoneal Fibrosis and Aortitis as the Initial Findings of Systemic Lupus Erythematosus Sistemik Lupus Eritematozusun Başlangıç Bulguları Olarak Retroperitoneal Fibrozis ve Aortitis Aynur SOYUÖZ,1 Metin IŞIK,2 İsmail DOĞAN,2 Levent KILIÇ,2 Sedat KİRAZ2 1Department of Internal Medicine, Medical Faculty of Hacettepe University, Ankara, Turkey; 2Department of Internal Medicine, Division of Rheumatology, Medical Faculty of Hacettepe University, Ankara, Turkey Retroperitoneal fibrosis (RPF) is characterized by Retroperitoneal fibrozis (RPF) progressif bağ doku progressive connective tissue proliferation which in proliferasyonu ile karakterize olup nadiren periaortik kitle rare cases forms a periaortic mass. Aortitis is clinically oluşturur. Aortitis sistemik lupus eritematozusta (SLE) uncommon in systemic lupus erythematosus (SLE), and klinik olarak nadirdir ve literatürde daha önce yaşayan only one previous case with aortitis has been reported in lupuslu yetişkin hastalarda yalnızca bir aortitis olgusu the literature in living adult patients with lupus. Herein, we bildirilmiştir. Burada, başlangıç SLE bulguları RPF ve report a case with RPF and aortitis as the initial findings aortitis olan bir SLE olgusu sunuldu. Hasta kliniğimize of SLE. The patient was admitted to our clinic with severe her iki avuç içinde ağrılı ve makülopapüler lezyonlarla abdominal pain, nausea, and photosensitivity along with birlikte şiddetli karın ağrısı, bulantı ve fotosensitivite ile
    [Show full text]
  • Sjögren's Syndrome with Polyserositis, Gastrointestinal Findings And
    : Ope gy n A lo c o c i e g s n s A Heper et al., Angiol 2017, 5:2 Angiology: Open Access DOI: 10.4172/2329-9495.1000193 ISSN: 2329-9495 Case Report Open Access Sjögren’s Syndrome with Polyserositis, Gastrointestinal Findings and Ascending Aortic Aneurysm Gulumser Heper, MD1*, Suha Cetin, MD1, Kemal Unal, MD2, Salih Salihi, MD3, Basak Bostancı, MD4, Murat Korkmaz, MD5 1Department of Cardiology, Okan University Medical Faculty, Istanbul, Turkey 2Department of Nuclear Medicine, Okan University Medical Faculty, Istanbul, Turkey 3Department of Cardiovascular Surgery, Okan University Medical Faculty, Istanbul, Turkey 4Department of Ophthalmology, Okan University Medical Faculty, Istanbul, Turkey 5Department of Gastroenterology, Okan University Medical Faculty, Istanbul, Turkey *Corresponding author: Gulumser Heper, Department of Cardiology, Okan University, Aydınlı Cad No:2 34947 İçmeler, Tuzla, Istanbul, Turkey, Tel: 00905325252999; E-mail: [email protected] Received date: 27 April, 2017; Accepted date: 05 May, 2017; Published date: 09 May, 2017 Copyright: © 2017 Heper G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Sjögren’s syndrome (SS) is an autoimmune disease with glandular and extraglandular manifestations. Pleural and pericardial effusions in association with SS are rare. Similarly, ascites is rare and it can occur in SS when combined with primary biliary cirrhosis (PBC). Inflammatory Abdominal Aortic Aneurysm together with SS has been described only in one case. We report herein the case of a 70-year-old man with SS presenting with polyserositis (pleural and pericardial effusion and ascites) and gastrointestinal manifestations (atrophic gastritis and candida esophagitis) and ascending aorta aneurysm.
    [Show full text]
  • A Rare but Potentially Lethal Case of Tuberculous Aortic Aneurysm Presenting with Repeated Attacks of Abdominal Pain
    □ CASE REPORT □ A Rare but Potentially Lethal Case of Tuberculous Aortic Aneurysm Presenting with Repeated Attacks of Abdominal Pain Yao-Min Hung 1-3, Yun-Te Chang 1-3, Jyh-Seng Wang 2,4, Paul Yung-Pou Wang 5 and Shue-Ren Wann 1-3 Abstract Tuberculous aortic aneurysm is an extremely rare disease with a high mortality rate. The clinical features of this condition are highly variable, ranging from asymptomatic with or without constitutional symptoms, abdominal pain to frank rupture, bleeding and shock. We herein report the case of a 56-year-old man with a large tuberculous mycotic aneurysm in the abdominal aorta with an initial presentation of repeated attacks of abdominal pain lasting for several months. Due to the vague nature of the initial symptoms, tuberculous aor- tic aneurysms may take several months to diagnose. This case highlights the importance of having a high in- dex of suspicion and providing timely surgery for this rare but potentially lethal disease. Key words: abdominal aortic aneurysm, abdominal pain, aneurysm, aorta, mycotic aneurysm, tuberculosis (Intern Med 54: 1145-1148, 2015) (DOI: 10.2169/internalmedicine.54.3620) a 56-year-old man who presented to the ED with repeated Introduction attacks of abdominal pain. Following a preoperative evalu- ation, including clinical and radiological assessments, he un- Tuberculosis (TB) remains a major global health problem. derwent successful repair of a mycotic aneurysm in the ab- This disease causes ill-health in millions of people each year dominal aorta with excision and replacement of the diseased and ranks as the second leading cause of death from infec- aorta.
    [Show full text]
  • Pyogenic Aortitis ― Role of 18F-FDG Positron Emission Tomography/Computed Tomography in Aortic Infection Imaging ―
    Advance Publication by-J-STAGE Circ J IMAGES IN CARDIOVASCULAR MEDICINE doi: 10.1253/circj.CJ-17-0455 Pyogenic Aortitis ― Role of 18F-FDG Positron Emission Tomography/Computed Tomography in Aortic Infection Imaging ― Alejandro Travieso-González, MD; Isidre Vilacosta, MD, PhD; David Vivas, MD, PhD; Carmen Olmos, MD, PhD; Javier Higueras Nafría, MD, PhD; María Jesús Pérez Castejón, MD, PhD; Aída Ortega Candil, MD, PhD; Adela Pelayo Alarcón, MD, PhD; Luis Ortega Medina, MD, PhD Figure. (A) Axial fused and unfused 18F-FDG positron emission tomography computed tomography (PET/CT) showing intense uptake of FDG (arrow) in the anterior wall of the ascending aorta, shortly after the initiation of cloxacillin. (B) 18F-FDG PET-CT after 4-week antibiotic treatment, showing increased uptake of the tracer compared with the previous one. (C) Macroscopic specimen of the inner surface of the ascending aorta and aortic valve. An ulcerated and necrotic atherosclerotic aortic plaque is clearly seen immediately above the left coronary sinus. (D) Hematoxylin stain of the aortic wall showing the aortic ulcerated plaque with necrotizing infection and an abundant inflammatory reaction underneath (arrow). n 85-year-old man with symptomatic severe aortic which indicated leukocytosis and elevation of inflammatory stenosis presented to the emergency room with markers (C-reactive protein, procalcitonin). Blood cultures A general discomfort, fever and chills. Two weeks showed oxacillin-sensitive S. aureus, and hence i.v. cloxa- earlier, he had been hospitalized for a pre-TAVI (trans- cillin was started. Physical exam and chest X-ray were catheter aortic valve implatation) study (angio-computed unremarkable. No signs of infective endocarditis were seen tomography and coronary angiography), and during on transthoracic and also transesophageal echocardiography.
    [Show full text]
  • Consensus Statement on Surgical Pathology of the Aorta, Part I
    Cardiovascular Pathology 24 (2015) 267–278 Contents lists available at ScienceDirect Cardiovascular Pathology Review Article Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardio- vascular Pathology: I. Inflammatory diseases James R. Stone a,⁎,PatrickBrunevalb,⁎⁎, Annalisa Angelini c, Giovanni Bartoloni d, Cristina Basso c, Lubov Batoroeva e,L.MaximilianBujaf, Jagdish Butany g, Giulia d'Amati h, John T. Fallon i, Adriana C. Gittenberger-de Groot j, Rosa H. Gouveia k, Marc K. Halushka l, Karen L. Kelly m, Ivana Kholova n, Ornella Leone o, Silvio H. Litovsky p, Joseph J. Maleszewski q, Dylan V. Miller r, Richard N. Mitchell s, Stephen D. Preston t,AngelaPucciu, Stanley J. Radio v,E.ReneRodriguezw, Mary N. Sheppard x, S. Kim Suvarna y, Carmela D. Tan w, Gaetano Thiene c, Allard C. van der Wal z, John P. Veinot aa a Massachusetts General Hospital, Boston, MA, USA b University Paris-Descartes, France c University of Padua Medical School, Padua, Italy d University of Catania, Catania, Italy e Russian Academy of Medical Sciences, Irkutsk, Russia f University of Texas Health Science Center at Houston, Houston, TX, USA g Toronto General Hospital, Toronto, Canada h Sapienza, University of Rome, Rome, Italy i New York Medical College, Valhalla, NY, USA j Leiden University, Leiden, the Netherlands k Hospital Santa Cruz, Carnaxide, Portugal l Johns Hopkins University, Baltimore, MD, USA m East Carolina University, Greenville, NC, USA n Fimlab Laboratories, Tampere,
    [Show full text]